Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Proect Grant - PA: Intersectionality in Sex, Gender and Health Research

University of Toronto

$100,000.00

Optimizing the vaginal microbiome In African, Caribbean and other Black women from Toronto, Canada: defining clinical endpoints and community priorities

FY 2023-24

Summary
The community of bacteria in the vagina of all women is known as the vaginal microbiome. Predominance by an "optimal" species of Lactobacillus (particularly Lactobacillus crispatus) is associated with reduced inflammation and improved reproductive health outcomes. However, a more diverse microbiome is defined as Bacterial Vaginosis (BV), which can cause increased inflammation and an enhanced risk of HIV/STIs, premature birth, and other adverse reproductive health outcomes. Although vaginal inflammation is dramatically reduced by antibiotic treatment, BV tends to reoccur soon after treatment. We recently showed that a probiotic containing L. crispatus substantially reduces both recurrence risk and genital inflammation. While BV is more common among African, Caribbean and other Black (ACB) women, not all ACB women with BV have vaginal inflammation and not all may need treatment. Aim #1. Led by Ms. Wangari Tharao and Dr. Notisha Massaquoi at the Women's Health in Women's Hands Community Health Centre (WHIWH), qualitative studies will explore: (1) vaginal health symptoms that are important to ACB women; and (2) community acceptability of future vaginal interventions, including factors such as route and frequency of application, the need for antibiotic treatment and the anticipated efficacy. Aim #2. Working with participants from WHIWH, we will assess how the microbiome and presence of inflammation in 200 ACB women correlate with a much more in-depth assessment of vaginal and sexual symptoms than has been done before. Aim #3. Current recommended treatment (a vaginal antibiotic gel) will be provided to 100 women found to have BV, and the impact on in-depth vaginal symptoms will be correlated with changes in the microbiome and reductions in inflammation. The information generated through this project will be critical for us to design the most effective future community-based interventions to optimize the vaginal microbiome and improve vaginal health for ACB women.
Program
Proect Grant - PA: Intersectionality in Sex, Gender and Health Research
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
494152
Name
Kaul Rupert
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Gender, Sex & Health
Projecttitle
Optimizing the vaginal microbiome In African, Caribbean and other Black women from Toronto, Canada: defining clinical endpoints and community priorities
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Proect Grant - PA: Intersectionality in Sex, Gender and Health Research
Keyworddelim
African, Caribbean And Other Black Communities; Bacterial Vaginosis; Inflammation; Probiotic; Reproductive Health; Vaginal Microbiome
Abstract
The community of bacteria in the vagina of all women is known as the vaginal microbiome. Predominance by an "optimal" species of Lactobacillus (particularly Lactobacillus crispatus) is associated with reduced inflammation and improved reproductive health outcomes. However, a more diverse microbiome is defined as Bacterial Vaginosis (BV), which can cause increased inflammation and an enhanced risk of HIV/STIs, premature birth, and other adverse reproductive health outcomes. Although vaginal inflammation is dramatically reduced by antibiotic treatment, BV tends to reoccur soon after treatment. We recently showed that a probiotic containing L. crispatus substantially reduces both recurrence risk and genital inflammation. While BV is more common among African, Caribbean and other Black (ACB) women, not all ACB women with BV have vaginal inflammation and not all may need treatment. Aim #1. Led by Ms. Wangari Tharao and Dr. Notisha Massaquoi at the Women's Health in Women's Hands Community Health Centre (WHIWH), qualitative studies will explore: (1) vaginal health symptoms that are important to ACB women; and (2) community acceptability of future vaginal interventions, including factors such as route and frequency of application, the need for antibiotic treatment and the anticipated efficacy. Aim #2. Working with participants from WHIWH, we will assess how the microbiome and presence of inflammation in 200 ACB women correlate with a much more in-depth assessment of vaginal and sexual symptoms than has been done before. Aim #3. Current recommended treatment (a vaginal antibiotic gel) will be provided to 100 women found to have BV, and the impact on in-depth vaginal symptoms will be correlated with changes in the microbiome and reductions in inflammation. The information generated through this project will be critical for us to design the most effective future community-based interventions to optimize the vaginal microbiome and improve vaginal health for ACB women.
Competitiondate
202309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kaul, Rupert
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~